How the Wnt signaling pathway protects from neurodegeneration: The mitochondrial scenario

Frontiers in Cellular Neuroscience

Volumn 9, Issue MAY, 2015, Pages

  Arrázola, Macarena S ^a   Silva Alvarez, Carmen ^a   Inestrosa, Nibaldo C ^a,b,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSIDAD DE MAGALLANES   (Chile)

Author keywords

Alzheimer s disease; Amyloid beta; Drp1; Electron microscopy; Mitochondrial dynamics; Permeability transition; Wnt

Indexed keywords

1, 2, 3, 6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; AMYLOID; AMYLOID BETA PROTEIN; CYCLOPHILIN D; DYNAMIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE; LIGAND; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOFUSIN 1; MITOFUSIN 2; N BENZYL 1, 2, 3, 4, 8, 9 HEXAHYDRO 6 (4 HYDROXYBENZYL) 8 (1 NAPHTHYLMETHYL) 4, 7 DIOXO 2H PYRAZINO [1, 2 A] PYRIMIDINE 1 (6H) CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLIGOMER; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; WNT3A LIGAND; WNT5A LIGAND;

ALZHEIMER DISEASE; ARTICLE; CALCIUM SIGNALING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PERMEABILITY; NERVE DEGENERATION; NEUROPROTECTION; PARKINSON DISEASE; WNT SIGNALING PATHWAY;

EID: 84929579761     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00166     Document Type: Article

References (170)

1. Alberio, T., Lopiano, L., and Fasano, M. (2012). Cellular models to investigate biochemical pathways in Parkinson’s disease. FEBS J. 279, 1146-1155. doi: 10.1111/j.1742-4658.2012.08516.x
2. Alford, S., Frenguelli, B. G., Schofield, J. G., and Collingridge, G. L. (1993). Characterization of Ca2+ signals induced in hippocampal CA1 neurones by the synaptic activation of NMDA receptors. J. Physiol. 469, 693-716. doi: 10.1113/jphysiol.1993.sp019838
3. Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., and Inestrosa, N. C. (2004). Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 297, 186-196. doi: 10.1016/j.yexcr.2004.02.028
4. Arrázola, M. S., and Inestrosa, N. C. (2013). ‘‘Wnt3a ligand prevents mitochondrial permeability transition pore opening induced by Aβ oligomers,’’ in Program of the XXVII Annual Meeting of the Chilean Society for Cell Biology (Puerto Varas-Chile), 23-27.
5. Arrázola, M. S., and Inestrosa, N. C. (2015). ‘‘Monitoring mitochondrial membranes permeability in live neurons and mitochondrial swelling through electron microscopy analysis,’’ in Neuronal Cell Death. Methods in Molecular Biology (Vol. 1254), eds L. Lossi and A. Merighi (New York: Springer), 87-97.
6. Arrázola, M. S., Varela-Nallar, L., Colombres, M., Toledo, E. M., Cruzat, F., Pavez, L., et al. (2009). Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. J. Cell. Physiol. 221, 658-667. doi: 10.1002/jcp.21902
7. Babcock, D. F., Herrington, J., Goodwin, P. C., Park, Y. B., and Hille, B. (1997). Mitochondrial participation in the intracellular Ca2+ network. J. Cell Biol. 136, 833-844. doi: 10.1083/jcb.136.4.833
8. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662. doi: 10.1038/nature03434
9. Balietti, M., Giorgetti, B., Casoli, T., Solazzi, M., Tamagnini, F., Burattini, C., et al. (2013). Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer’s disease. J. Alzheimers Dis. 34, 887-896. doi: 10.3233/JAD-121711
10. Barsoum, M. J., Yuan, H., Gerencser, A. A., Liot, G., Kushnareva, Y., Gräber, S., et al. (2006). Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25, 3900-3911. doi: 10.1038/sj.emboj.7601253
11. Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., et al. (2009). Clearance mechanisms of Alzheimer’s amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol. Psychiatry 14, 469-486. doi: 10.1038/mp.2008.96
12. Berridge, M. J. (1998). Neuronal calcium signaling. Neuron 21, 13-26. doi: 10.1016/s0896-6273(00)80510-3
13. Berridge, M. J. (2011). Calcium signalling and Alzheimer’s disease. Neurochem. Res. 36, 1149-1156. doi: 10.1007/s11064-010-0371-4
14. Bezprozvanny, I., and Mattson, M. P. (2008). Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Trends Neurosci. 31, 454-463. doi: 10.1016/j.tins.2008.06.005
15. Billups, B., and Forsythe, I. D. (2002). Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci. 22, 5840-5847.
16. Blandini, F., and Armentero, M.-T. (2012). Animal models of Parkinson’s disease. FEBS J. 279, 1156-1166. doi: 10.1111/j.1742-4658.2012.08491.x
17. Burté, F., Carelli, V., Chinnery, P. F., and Yu-Wai-Man, P. (2015). Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11-24. doi: 10.1038/nrneurol.2014.228
18. Canevari, L., Clark, J. B., and Bates, T. E. (1999). β-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457, 131-134. doi: 10.1016/s0014-5793(99)01028-5
19. Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., et al. (2005). Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease. FASEB J. 19, 2040-2041. doi: 10.1096/fj.05-3735fje
20. Celsi, F., Pizzo, P., Brini, M., Leo, S., Fotino, C., Pinton, P., et al. (2009). Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim. Biophys. Acta 1787, 335-344. doi: 10.1016/j.bbabio.2009.02.021
21. Cereghetti, G. M., Stangherlin, A., Martins de Brito, O., Chang, C. R., Blackstone, C., Bernardi, P., et al. (2008). Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. U S A 105, 15803-15808. doi: 10.1073/pnas.0808249105
22. Cerpa, W., Dinamarca, M. C., and Inestrosa, N. C. (2008). Structure-function implications in Alzheimer’s disease: effect of Aβ oligomers at central synapses. Curr. Alzheimer Res. 5, 233-243. doi: 10.2174/156720508784533321
23. Cerpa, W., Farías, G. G., Godoy, J. A., Fuenzalida, M., Bonansco, C., and Inestrosa, N. C. (2010). Wnt-5a occludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol. Neurodegener. 5:3. doi: 10.1186/1750-1326-5-3
24. Cerpa, W., Toledo, E. M., Varela-Nallar, L., and Inestrosa, N. C. (2009). The role of Wnt signaling in neuroprotection. Drug News Perspect. 22, 579-591. doi: 10.1358/dnp.2009.10.1436817
25. Chacón, M. A., Varela-Nallar, L., and Inestrosa, N. C. (2008). Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Aβ oligomers. J. Cell. Physiol. 217, 215-227. doi: 10.1002/jcp.21497
26. Chang, C.-R., and Blackstone, C. (2010). Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. N Y Acad. Sci. 1201, 34-39. doi: 10.1111/j.1749-6632.2010.05629.x
27. Chang, C.-R., Manlandro, C. M., Arnoult, D., Stadler, J., Posey, A. E., Hill, R. B., et al. (2010). A lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division. J. Biol. Chem. 285, 32494-32503. doi: 10.1074/jbc.m110.142430
28. Chen, J. X., and Yan, S. S. (2010). Role of mitochondrial amyloid-beta in Alzheimer’s disease. J. Alzheimers Dis. 20(Suppl. 2), S569-S578. doi: 10.3233/JAD-2010-100357
29. Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W. S., Juhaszova, M., et al. (2008). Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One 3:e1852. doi: 10.1371/journal.pone.0001852
30. Cho, D.-H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., et al. (2009). S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105. doi: 10.1126/science.1171091
31. Chow, V. W., Mattson, M. P., Wong, P. C., and Gleichmann, M. (2010). An overview of APP processing enzymes and products. Neuromolecular Med. 12, 1-12. doi: 10.1007/s12017-009-8104-z
32. Cipolat, S., Martins de Brito, O., Dal Zilio, B., and Scorrano, L. (2004). OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. USA101,15927-15932.doi:10.1073/pnas.0407043101
33. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., et al. (2005). Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84. doi: 10.1038/nn1372
34. Clevers, H., and Nusse, R. (2012). Wnt/β-catenin signaling and disease. Cell 149, 1192-1205. doi: 10.1016/j.cell.2012.05.012
35. Connern, C. P., and Halestrap, A. P. (1994). Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302(Pt. 2), 321-324.
36. Cribbs, J. T., and Strack, S. (2007). Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8, 939-944. doi: 10.1038/sj.embor.7401062
37. Crompton, M., Virji, S., and Ward, J. M. (1998). Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258, 729-735. doi: 10.1046/j.1432-1327.1998.2580729.x
38. Cuitino, L., Godoy, J. A., Farías, G. G., Couve, A., Bonansco, C., Fuenzalida, M., et al. (2010). Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. J. Neurosci. 30, 8411-8420. doi: 10.1523/JNEUROSCI.5736-09.2010
39. De Ferrari, G. V., Chacón, M. A., Barría, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., et al. (2003). Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatry 8, 195-208. doi: 10.1038/sj.mp.4001208
40. De Ferrari, G. V., and Inestrosa, N. C. (2000). Wnt signaling function in Alzheimer’s disease. Brain Res. Brain Res. Rev. 33, 1-12. doi: 10.1016/S0165-0173(00)00021-7
41. Demuro, A., Parker, I., and Stutzmann, G. E. (2010). Calcium signaling and amyloid toxicity in Alzheimer disease. J. Biol. Chem. 285, 12463-12468. doi: 10.1074/jbc.R109.080895
42. De Pinto, V., Guarino, F., Guarnera, A., Messina, A., Reina, S., Tomasello, F. M., et al. (2010). Characterization of human VDAC isoforms: a peculiar function for VDAC3? Biochim. Biophys. Acta 1797, 1268-1275. doi: 10.1016/j.bbabio.2010.01.031
43. Detmer, S. A., and Chan, D. C. (2007). Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell Biol. 8, 870-879. doi: 10.1038/nrm2275
44. Devi, L., and Anandatheerthavarada, H. K. (2010). Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases. Biochim. Biophys. Acta 1802, 11-19. doi: 10.1016/j.bbadis.2009.07.007
45. Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., and Anandatheerthavarada, H. K. (2006). Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26, 9057-9068. doi: 10.1523/jneurosci.1469-06.2006
46. Dinamarca, M. C., Cerpa, W., Garrido, J., Hancke, J. L., and Inestrosa, N. C. (2006). Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer’s amyloid-beta-deposits. Mol. Psychiatry 11, 1032-1048. doi: 10.1038/sj.mp.4001866
47. Dinamarca, M. C., Sagal, J. P., Quintanilla, R. A., Godoy, J. A., Arrázola, M. S., and Inestrosa, N. C. (2010). Amyloid-β-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Aβ peptide. Implications for the pathogenesis of Alzheimer’s disease. Mol. Neurodegener. 5:4. doi: 10.1186/1750-1326-5-4
48. Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., et al. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat. Med. 14, 1097-1105. doi: 10.1038/nm.1868
49. Du, H., Guo, L., Yan, S., Sosunov, A. A., McKhann, G. M., and Yan, S. S. (2010). Early deficits in synaptic mitochondria in an Alzheimer’s disease mouse model. Proc. Natl. Acad. Sci. U S A 107, 18670-18675. doi: 10.1073/pnas.1006586107
50. Du, H., and Yan, S. S. (2010a). Mitochondrial medicine for neurodegenerative diseases. Int. J. Biochem. Cell Biol. 42, 560-572. doi: 10.1016/j.biocel.2010.01.004
51. Du, H., and Yan, S. S. (2010b). Mitochondrial permeability transition pore in Alzheimer’s disease: cyclophilin D and amyloid beta. Biochim. Biophys. Acta 1802, 198-204. doi: 10.1016/j.bbadis.2009.07.005
52. Eckert, A., Keil, U., Marques, C. A., Bonert, A., Frey, C., Schüssel, K., et al. (2003). Mitochondrial dysfunction, apoptotic cell death and Alzheimer’s disease. Biochem. Pharmacol. 66, 1627-1634. doi: 10.1016/s0006-2952(03)00534-3
53. Eliseev, R. A., Malecki, J., Lester, T., Zhang, Y., Humphrey, J., and Gunter, T. E. (2009). Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J. Biol. Chem. 284, 9692-9699. doi: 10.1074/jbc.M808750200
54. Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., et al. (2004). A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. Proc. Natl. Acad. Sci. U S A 101, 12682-12687. doi: 10.1073/pnas.0404875101
55. Eura, Y., Ishihara, N., Yokota, S., and Mihara, K. (2003). Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J. Biochem. 134, 333-344. doi: 10.1093/jb/mvg150
56. Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., et al. (2007). Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27, 12413-12418. doi: 10.1523/jneurosci.0719-07.2007
57. Farías, G. G., Alfaro, I. E., Cerpa, W., Grabowski, C. P., Godoy, J. A., Bonansco, C., et al. (2009). Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. J. Biol. Chem. 284, 15857-15866. doi: 10.1074/jbc.m808986200
58. Ferreira, S. T., Vieira, M. N. N., and De Felice, F. G. (2007). Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases. IUBMB Life 59, 332-345. doi: 10.1080/15216540701283882
59. Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., et al. (2006). Mild cognitive impairment. Lancet 367, 1262-1270. doi: 10.1016/S0140-6736(06)68542-5
60. Gillessen, T., Grasshoff, C., and Szinicz, L. (2002). Mitochondrial permeability transition can be directly monitored in living neurons. Biomed. Pharmacother. 56, 186-193. doi: 10.1016/s0753-3322(02)00184-1
61. Godoy, J. A., Arrázola, M. S., Ordenes, D., Silva-Alvarez, C., Braidy, N., and Inestrosa, N. C. (2014). Wnt-5a ligand modulates mitochondrial fission-fusion in rat hippocampal neurons. J. Biol. Chem. 289, 36179-36193. doi: 10.1074/jbc.M114.557009
62. Gomez, L., Paillard, M., Thibault, H., Derumeaux, G., and Ovize, M. (2008). Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117, 2761-2768. doi: 10.1161/CIRCULATIONAHA.107.755066
63. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112. doi: 10.1038/nrm2101
64. Halestrap, A. P. (2009). What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 46, 821-831. doi: 10.1016/j.yjmcc.2009.02.021
65. Halestrap, A. P., Connern, C. P., Griffiths, E. J., and Kerr, P. M. (1997). Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol. Cell. Biochem. 174, 167-172. doi: 10.1007/978-1-4615-6111-8_25
66. Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., et al. (2008). The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. U S A 105, 13145-13150. doi: 10.1073/pnas.0806192105
67. Hardy, J. A., and Higgins, G. A. (1992). Alzheimer’s disease: the amyloid cascade hypothesis. Science 256, 184-185. doi: 10.1126/science.1566067
68. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
69. Harvey, K., and Marchetti, B. (2014). Regulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration. J. Mol. Cell Biol. 6, 1-2.doi: 10.1093/jmcb/mju002
70. Hoppins, S. (2014). The regulation of mitochondrial dynamics. Curr. Opin. Cell Biol. 29, 46-52. doi: 10.1016/j.ceb.2014.03.005
71. Hoppins, S., Lackner, L., and Nunnari, J. (2007). The machines that divide and fuse mitochondria. Annu. Rev. Biochem. 76, 751-780. doi: 10.1146/annurev.biochem.76.071905.090048
72. Inestrosa, N. C., and Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nat. Rev. Neurosci. 11, 77-86. doi: 10.1038/nrn2755
73. Inestrosa, N. C., and Varela-Nallar, L. (2014). Wnt signaling in the nervous system and in Alzheimer’s disease. J. Mol. Cell Biol. 6, 64-74. doi: 10.1093/jmcb/mjt051
74. Inestrosa, N. C., and Varela-Nallar, L. (2015). Wnt signalling in neuronal differentiation and development. Cell Tissue Res. 359, 215-223. doi: 10.1007/s00441-014-1996-4
75. Itoh, K., Nakamura, K., Iijima, M., and Sesaki, H. (2013). Mitochondrial dynamics in neurodegeneration. Trends Cell Biol. 23, 64-71. doi: 10.1016/j.tcb.2012.10.006
76. Juhaszova, M., Zorov, D. B., Kim, S., Pepe, S., Fu, Q., Fishbein, K. W., et al. (2004). Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113, 1535-1549. doi: 10.1172/JCI200419906
77. Juhaszova, M., Zorov, D. B., Yaniv, Y., Nuss, H. B., Wang, S., and Sollott, S. J. (2009). Role of glycogen synthase kinase-3beta in cardioprotection. Circ. Res. 104, 1240-1252. doi: 10.1161/CIRCRESAHA.109.197996
78. Kageyama, Y., Zhang, Z., and Sesaki, H. (2011). Mitochondrial division: molecular machinery and physiological functions. Curr. Opin. Cell Biol. 23, 427-434.doi: 10.1016/j.ceb.2011.04.009
79. Klein, P. S., and Melton, D. A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U S A 93, 8455-8459. doi: 10.1073/pnas.93.16.8455
80. Kornmann, B. (2014). Quality control in mitochondria: use it, break it, fix it, trash it. F1000Prime Rep. 6:15. doi: 10.12703/P6-15
81. Koshiba, T., Detmer, S. A., Kaiser, J. T., Chen, H., McCaffery, J. M., and Chan, D. C. (2004). Structural basis of mitochondrial tethering by mitofusin complexes. Science 305, 858-862. doi: 10.1126/science.1099793
82. Labrousse, A. M., Zappaterra, M. D., Rube, D. A., and van der Bliek, A. M. (1999). C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol. Cell 4, 815-826. doi: 10.1016/s1097-2765(00)80391-3
83. LaFerla, F. M. (2002). Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat. Rev. Neurosci. 3, 862-872. doi: 10.1038/nrn960
84. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., et al. (1998). Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U S A 95, 6448-6453. doi: 10.1073/pnas.95.11.6448
85. Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., and Selkoe, D. (2009). Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801. doi: 10.1016/j.neuron.2009.05.012
86. Li, Z., Okamoto, K.-I., Hayashi, Y., and Sheng, M. (2004). The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887. doi: 10.1016/j.cell.2004.11.003
87. Lie, D.-C., Colamarino, S. A., Song, H.-J., Désiré, L., Mira, H., Consiglio, A., et al. (2005). Wnt signalling regulates adult hippocampal neurogenesis. Nature 437, 1370-1375. doi: 10.1038/nature04108
88. Liu, C.-C., Tsai, C.-W., Deak, F., Rogers, J., Penuliar, M., Sung, Y. M., et al. (2014). Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer’s disease. Neuron 84, 63-77. doi: 10.1016/j.neuron.2014.08.048
89. Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., et al. (2004). ABAD directly links Aβ to mitochondrial toxicity in Alzheimer’s disease. Science 304, 448-452. doi: 10.1126/science.1091230
90. Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., and Reddy, P. H. (2006). Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437-1449. doi: 10.1093/hmg/ddl066
91. Manczak, M., Calkins, M. J., and Reddy, P. H. (2011). Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer’s disease: implications for neuronal damage. Hum. Mol. Genet. 20, 2495-2509. doi: 10.1093/hmg/ddr139
92. Manczak, M., and Reddy, P. H. (2012). Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer’s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 21, 2538-2547. doi: 10.1093/hmg/dds072
93. Marks, A. R. (1997). Intracellular calcium-release channels: regulators of cell life and death. Am. J. Physiol. 272, H597-H605.
94. Mattson, M. P. (2004). Pathways towards and away from Alzheimer’s disease. Nature 430, 631-639. doi: 10.1038/nature02621
95. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992). β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389
96. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., et al. (1999). Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann. Neurol. 46, 860-866. doi: 10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
97. Medler, K., and Gleason, E. L. (2002). Mitochondrial Ca(2+) buffering regulates synaptic transmission between retinal amacrine cells. J. Neurophysiol. 87, 1426-1439. doi: 10.1152/jn.00627.2001
98. Messina, A., Reina, S., Guarino, F., and De Pinto, V. (2012). VDAC isoforms in mammals. Biochim. Biophys. Acta 1818, 1466-1476. doi: 10.1016/j.bbamem. 2011.10.005
99. Miura, T., Nishihara, M., and Miki, T. (2009). Drug development targeting the glycogen synthase kinase-3β (GSK-3β)-mediated signal transduction pathway: role of GSK-3β in myocardial protection against ischemia/reperfusion injury. J. Pharmacol. Sci. 109, 162-167. doi: 10.1254/jphs.08r27fm
100. Miura, T., and Tanno, M. (2010). Mitochondria and GSK-3β in cardioprotection against ischemia/reperfusion injury. Cardiovasc. Drugs Ther. 24, 255-263. doi: 10.1007/s10557-010-6234-z
101. Miyamoto, S., Murphy, A. N., and Brown, J. H. (2008). Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 15, 521-529. doi: 10.1038/sj.cdd.4402285
102. Moreira, P. I., Santos, M. S., Moreno, A., and Oliveira, C. (2001). Amyloid β-peptide promotes permeability transition pore in brain mitochondria. Biosci. Rep. 21, 789-800. doi: 10.1023/A1015536808304
103. Moreira, P. I., Santos, M. S., Moreno, A., Rego, A. C., and Oliveira, C. (2002). Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J. Neurosci. Res. 69, 257-267. doi: 10.1002/jnr.10282
104. Moreira, P. I., Santos, M. S., and Oliveira, C. R. (2007). Alzheimer’s disease: a lesson from mitochondrial dysfunction. Antioxid. Redox Signal. 9, 1621-1630. doi: 10.1089/ars.2007.1703
105. Morgan, C., Colombres, M., Nuñez, M. T., and Inestrosa, N. C. (2004). Structure and function of amyloid in Alzheimer’s disease. Prog. Neurobiol. 74, 323-349. doi: 10.1016/j.pneurobio.2004.10.004
106. Morris, R. L., and Hollenbeck, P. J. (1993). The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J. Cell Sci. 104(Pt. 3), 917-927.
107. Mosconi, L. (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging 32, 486-510.doi: 10.1007/s00259-005-1762-7
108. Muirhead, K. E. A., Borger, E., Aitken, L., Conway, S. J., and Gunn-Moore, F. J. (2010). The consequences of mitochondrial amyloid beta-peptide in Alzheimer’s disease. Biochem. J. 426, 255-270. doi: 10.1042/BJ20091941
109. Newmeyer, D. D., and Ferguson-Miller, S. (2003). Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112, 481-490. doi: 10.1016/S0092-8674(03)00116-8
110. Nishihara, M., Miura, T., Miki, T., Tanno, M., Yano, T., Naitoh, K., et al. (2007). Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection. J. Mol. Cell. Cardiol. 43, 564-570. doi: 10.1016/j.yjmcc.2007.08.010
111. Oliva, C. A., Vargas, J. Y., and Inestrosa, N. C. (2013). Wnts in adult brain: from synaptic plasticity to cognitive deficiencies. Front. Cell. Neurosci. 7:224. doi: 10.3389/fncel.2013.00224
112. Paula-Lima, A. C., Adasme, T., SanMartín, C., Sebollela, A., Hetz, C., Carrasco, M. A., et al. (2011). Amyloid β-peptide oligomers stimulate RyR-mediated Ca2+ release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. Antioxid. Redox Signal. 14, 1209-1223. doi: 10.1089/ars.2010.3287
113. Petronilli, V., Penzo, D., Scorrano, L., Bernardi, P., and Di Lisa, F. (2001). The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J. Biol. Chem. 276, 12030-12034. doi: 10.1074/jbc.m010604200
114. Qi, X., Disatnik, M.-H., Shen, N., Sobel, R. A., and Mochly-Rosen, D. (2011). Aberrant mitochondrial fission in neurons induced by protein kinase Cdelta under oxidative stress conditions in vivo. Mol. Biol. Cell 22, 256-265. doi: 10.1091/mbc.E10-06-0551
115. Quintanilla, R. A., Muñoz, F. J., Metcalfe, M. J., Hitschfeld, M., Olivares, G., Godoy, J. A., et al. (2005). Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J. Biol. Chem. 280, 11615-11625. doi: 10.1074/jbc.m411936200
116. Rao, V. K., Carlson, E. A., and Yan, S. S. (2014). Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim. Biophys. Acta 1842, 1267-1272. doi: 10.1016/j.bbadis.2013.09.003
117. Rasola, A., Sciacovelli, M., Chiara, F., Pantic, B., Brusilow, W. S., and Bernardi, P. (2010a). Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc. Natl. Acad. Sci. U S A 107, 726-731. doi: 10.1073/pnas.0912742107
118. Rasola, A., Sciacovelli, M., Pantic, B., and Bernardi, P. (2010b). Signal transduction to the permeability transition pore. FEBS Lett. 584, 1989-1996. doi: 10.1016/j.febslet.2010.02.022
119. Reddy, P. H. (2006). Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer’s disease. J. Neurochem. 96, 1-13. doi: 10.1111/j.1471-4159.2005.03530.x
120. Reddy, P. H. (2009). Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease. Exp. Neurol. 218, 286-292. doi: 10.1016/j.expneurol.2009.03.042
121. Reddy, P. H. (2013). Amyloid β-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer’s disease: implications for synaptic dysfunction and neuronal damage. Biochim. Biophys. Acta 1832, 1913-1921. doi: 10.1016/j.bbadis.2013.06.012
122. Robey, R. B., and Hay, N. (2006). Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25, 4683-4696. doi: 10.1038/sj.onc.1209595
123. Rojo, M., Legros, F., Chateau, D., and Lombès, A. (2002). Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 115, 1663-1674.
124. Ross, C. A., and Poirier, M. A. (2005). Opinion: what is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6, 891-898. doi: 10.1038/nrm1742
125. Rosso, S. B., and Inestrosa, N. C. (2013). WNT signaling in neuronal maturation and synaptogenesis. Front. Cell. Neurosci. 7:103. doi: 10.3389/fncel.2013.00103
126. Rosso, S. B., Sussman, D., Wynshaw-Boris, A., and Salinas, P. C. (2005). Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8, 34-42. doi: 10.1038/nn1374
127. Ruthel, G., and Hollenbeck, P. J. (2003). Response of mitochondrial traffic to axon determination and differential branch growth. J. Neurosci. 23, 8618-8624.
128. Sakono, M., and Zako, T. (2010). Amyloid oligomers: formation and toxicity of Aβ oligomers. FEBS J. 277, 1348-1358. doi: 10.1111/j.1742-4658.2010.07568.x
129. Salinas, P. C., and Zou, Y. (2008). Wnt signaling in neural circuit assembly. Annu. Rev. Neurosci. 31, 339-358. doi: 10.1146/annurev.neuro.31.060407.125649
130. Sanmartin, C. D., Adasme, T., Hidalgo, C., and Paula-Lima, A. C. (2012). The antioxidant N-acetylcysteine prevents the mitochondrial fragmentation induced by soluble amyloid-β peptide oligomers. Neurodegener. Dis. 10, 34-37. doi: 10.1159/000334901
131. Saraiva, L. M., Seixas da Silva, G. S., Galina, A., da-Silva, W. S., Klein, W. L., Ferreira, S. T., et al. (2010). Amyloid-β triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One 5:e15230. doi: 10.1371/journal. pone.0015230
132. Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., et al. (2005). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U S A 102, 12005-12010.doi: 10.1073/pnas.0505294102
133. Schon, E. A., and Przedborski, S. (2011). Mitochondria: the next (neurode)generation. Neuron 70, 1033-1053. doi: 10.1016/j.neuron.2011.06.003
134. Sheng, Z.-H., and Cai, Q. (2012). Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci. 13, 77-93. doi: 10.1038/nrn3156
135. Shoshan-Barmatz, V., De Pinto, V., Zweckstetter, M., Raviv, Z., Keinan, N., and Arbel, N. (2010). VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med. 31, 227-285. doi: 10.1016/j.mam.2010.03.002
136. Silva-Alvarez, C., Arrázola, M. S., Godoy, J. A., Ordenes, D., and Inestrosa, N. C. (2013). Canonical Wnt signaling protects hippocampal neurons from Aβ oligomers: role of non-canonical Wnt-5a/Ca(2+) in mitochondrial dynamics. Front. Cell. Neurosci. 7:97. doi: 10.3389/fncel.2013.00097
137. Singh, P., Suman, S., Chandna, S., and Das, T. K. (2009). Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer’s disease. Bioinformation 3, 440-445. doi: 10.6026/97320630003440
138. Smirnova, E., Griparic, L., Shurland, D. L., and van der Bliek, A. M. (2001). Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 12, 2245-2256. doi: 10.1091/mbc.12.8.2245
139. Song, Z., Ghochani, M., McCaffery, J. M., Frey, T. G., and Chan, D. C. (2009). Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol. Biol. Cell 20, 3525-3532. doi: 10.1091/mbc.E09-03-0252
140. Spät, A., Szanda, G., Csordás, G., and Hajnóczky, G. (2008). High-and low-calcium-dependent mechanisms of mitochondrial calcium signalling. Cell Calcium 44, 51-63. doi: 10.1016/j.ceca.2007.11.015
141. Stambolic, V., and Woodgett, J. R. (1994). Mitogen inactivation of glycogen synthase kinase-3 β in intact cells via serine 9 phosphorylation. Biochem. J. 303(Pt. 3), 701-704.
142. Stutzmann, G. E., Smith, I., Caccamo, A., Oddo, S., Parker, I., and Laferla, F. (2007). Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer’s mouse models. Ann. N Y Acad. Sci. 1097, 265-277. doi: 10.1196/annals.1379.025
143. Su, B., Wang, X., Zheng, L., Perry, G., Smith, M. A., and Zhu, X. (2010). Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim. Biophys. Acta 1802, 135-142. doi: 10.1016/j.bbadis.2009.09.013
144. Supnet, C., and Bezprozvanny, I. (2010). Neuronal calcium signaling, mitochondrial dysfunction and Alzheimer’s disease. J. Alzheimers Dis. 20(Suppl. 2), S487-S498. doi: 10.3233/JAD-2010-100306
145. Swerdlow, R. H., Burns, J. M., and Khan, S. M. (2010). The Alzheimer’s disease mitochondrial cascade hypothesis. J. Alzheimers Dis. 20(Suppl. 2), S265-S279. doi: 10.3233/JAD-2010-100339
146. Szalai, G., Krishnamurthy, R., and Hajnóczky, G. (1999). Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J. 18, 6349-6361. doi: 10.1093/emboj/18.22.6349
147. Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., and Mihara, K. (2007). Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282, 11521-11529. doi: 10.1074/jbc.m607279200
148. Tamura, Y., Itoh, K., and Sesaki, H. (2011). SnapShot: mitochondrial dynamics. Cell 145, 1158-1158.e1. doi: 10.1016/j.cell.2011.06.018
149. Tanno, M., Kuno, A., Ishikawa, S., Miki, T., Kouzu, H., Yano, T., et al. (2014). Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2). J. Biol. Chem. 289, 29285-29296. doi: 10.1074/jbc.M114.563924
150. Toledo, E. M., and Inestrosa, N. C. (2010). Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer’s disease. Mol. Psychiatry 15, 272-285,. doi: 10.1038/mp.2009.72
151. Tsujimoto, Y., and Shimizu, S. (2007). Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12, 835-840. doi: 10.1007/s10495-006-0525-7
152. Varela-Nallar, L., Alfaro, I. E., Serrano, F. G., Parodi, J., and Inestrosa, N. C. (2010). Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc. Natl. Acad. Sci. U S A 107, 21164-21169. doi: 10.1073/pnas.1010011107
153. Varela-Nallar, L., and Inestrosa, N. C. (2013). Wnt signaling in the regulation of adult hippocampal neurogenesis. Front. Cell. Neurosci. 7:100. doi: 10.3389/fncel.2013.00100
154. Vargas, J. Y., Fuenzalida, M., and Inestrosa, N. C. (2014). In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer’s disease model. J. Neurosci. 34, 2191-2202. doi: 10.1523/jneurosci.0862-13.2014
155. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. doi: 10.1038/416535a
156. Wang, H., Song, P., Du, L., Tian, W., Yue, W., Liu, M., et al. (2011). Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J. Biol. Chem. 286, 11649-11658. doi: 10.1074/jbc.m110.144238
157. Wang, X., Su, B., Lee, H., Li, X., Perry, G., Smith, M. A., et al. (2009). Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J. Neurosci. 29, 9090-9103. doi: 10.1523/JNEUROSCI.1357-09.2009
158. Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., et al. (2008). Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U S A 105, 19318-19323. doi: 10.1073/pnas.0804871105
159. Wang, X., Yan, M. H., Fujioka, H., Liu, J., Wilson-delfosse, A., Chen, S. G., et al. (2012). LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 21, 1931-1944. doi: 10.1093/hmg/dds003
160. Westermann, B. (2010). Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11, 872-884. doi: 10.1038/nrm3013
161. Willert, K., and Nusse, R. (2012). Wnt proteins. Cold Spring Harb. Perspect. Biol. 4:a007864. doi: 10.1101/cshperspect.a007864
162. Wilson, T. J., Slupe, A. M., and Strack, S. (2013). Cell signaling and mitochondrial dynamics: implications for neuronal function and neurodegenerative disease. Neurobiol. Dis. 51, 13-26. doi: 10.1016/j.nbd.2012.01.009
163. Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., et al. (2001). Intraneuronal Aβ accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306, 116-120. doi: 10.1016/s0304-3940(01)01876-6
164. Xie, W., and Chung, K. K. K. (2012). Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s disease. J. Neurochem. 122, 404-414. doi: 10.1111/j.1471-4159.2012.07769.x
165. Yan, M. H., Wang, X., and Zhu, X. (2013). Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med. 62, 90-101. doi: 10.1016/j.freeradbiomed.2012.11.014
166. Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., and Brinton, R. D. (2009). Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U S A 106, 14670-14675. doi: 10.1073/pnas.0903563106
167. Yoon, Y., Galloway, C. A., Jhun, B. S., and Yu, T. (2011). Mitochondrial dynamics in diabetes. Antioxid. Redox Signal. 14, 439-457. doi: 10.1089/ars.2010.3286
168. Youle, R. J., and van der Bliek, A. M. (2012). Mitochondrial fission, fusion and stress. Science 337, 1062-1065. doi: 10.1126/science.1219855
169. Yu, C., Nwabuisi-Heath, E., Laxton, K., and Ladu, M. J. (2010). Endocytic pathways mediating oligomeric Aβ42 neurotoxicity. Mol. Neurodegener. 5:19. doi: 10.1186/1750-1326-5-19
170. Zorov, D. B., Juhaszova, M., Yaniv, Y., Nuss, H. B., Wang, S., and Sollott, S. J. (2009). Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc. Res. 83, 213-225. doi: 10.1093/cvr/cvp151